Ferrari’s meteoric rise is not driven by production volume. While mass-market manufacturers like Volkswagen battle weak ...

The Credit Suisse Pension Fund's Brunaupark residential construction project, which has been in the planning stage for years, has been freed from the city's extended right to have a say. A legal ...

The investment company BB Biotech, which specializes in the pharmaceutical sector, has confirmed its preliminary figures for the 2024 financial year. Looking ahead, increased activity is expected.

The decline is primarily attributable to the interest rate reversal. Net interest income decreased by 8,8 percent or 5,0 million francs to 51.0 million francs, after rising by 29 percent in the record ...

Rothschild & Co Bank in Zurich recently opened an office in Dubai and sees tremendous opportunities there. Nevertheless, ...

As consolidation in the Swiss wealth management sector continues, Rothschild & Co Bank primarily focuses on organic growth while remaining open to acquisitions. New hires are expected to drive revenue ...

The market for longevity services is expanding. Recently, Care, a Swiss HealthTech company, opened a dedicated practice in ...

Uri KB has exceeded its own growth targets. However, value adjustments for default risks have reduced income and profit.

UBS is embroiled in multiple high-stakes legal battles worldwide, primarily linked to its Wealth Management division and the takeover of Credit Suisse. These cases, spanning from historical tax ...

Thurgauer KB was not quite able to maintain the high level of the previous year. However, profits are only slightly lower. The dividend is nevertheless set to be higher.

The Basel-based institution remains on a growth path, but its profit did not increase as strongly as in the previous year.

Zurich saw a significant increase in earnings in 2024, benefiting its shareholders. For the first time, the insurance group ...